- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
High-risk prostate cancer: Value of multi-modality 3T MRI-guided biopsies after previous negative biopsies - Abstract
November 21, 2011
Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead - Abstract
November 21, 2011
Effect of constipation on serum total prostate-specific antigen levels in men - Abstract
November 21, 2011
Modifiable prostate cancer risk reduction and early detection behaviors in black men - Abstract
November 21, 2011
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC) - Abstract
November 18, 2011
Focal cryotherapy for localized prostate cancer: A report from the national Cryo On-Line Database (COLD) Registry - Abstract
November 18, 2011
Prostate-cancer screening - what the U.S. Preventive Services Task Force left out - Abstract
November 18, 2011
One man at a time - resolving the PSA controversy - Abstract
November 18, 2011
Defining and predicting indolent and low risk prostate cancer - Abstract
November 18, 2011
Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: Treating to doses beyond 78 Gy - Abstract
November 18, 2011
Robot-assisted versus open radical prostatectomy: An evidence-based comparison - Abstract
November 17, 2011
Relationship of obesity, androgen receptor genotypes and biochemical failure after radical prostatectomy - Abstract
November 17, 2011
PSA doubling time predicts for the development of distant metastases for patients who fail 3DCRT Or IMRT using the Phoenix definition - Abstract
November 17, 2011
pT3 predictive factors in patients with a Gleason score of 6 in prostate biopsies - Abstract
November 17, 2011
Stratifying risk - the U.S. Preventive Services Task Force and prostate-cancer screening - Abstract
November 17, 2011
Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates - Abstract
November 17, 2011